AFFYMETRIX (AFFX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX)

AFFX 14.01

0.0%

Apr 1 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (1027)	10/22/1999 1:12:00 PM
From: jerryriti	Read Replies (1) of 1728

Their GeneChip is I believe created by a proprietary process. Their GeneChip allows researchers to do their screening faster and more efficiently, i.e., enormous cost savings and represents a true paradigm shift in drug research. Regarding their patents, I am not sophisticated enough to determine how well they can defend their property, but I did take the win against Incyte as indicating that they have a clear lead and will defend their intellectual property i.e. GeneChip is proprietary! More importantly, I believe that as their GeneChip system is more widely used(revenues increasing) they are more readily assured of return business(customers will not desire multiple vendors but will stay with the most advanced technology). It is stock I personally fel I cannot afford to be without even if I cannot be certain that they will prevail in patent disputes in the future! In conclusion, I do beleive that the win against Incyte points in the direction of a proprietary technolgy! Guess their is more conjecture in my answer than concrete evidence. You might find better answers at their web site...http://www.affymetrix.com/

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next